Beta-adrenergic receptor blocker

Beta-adrenergic receptor blocker has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest story, Oct 26, 2026: “Four heart failure drugs linked to fewer deaths in older adults”.

Intervention

1 paper studies itUpdated

1 new paper in 30 daysSee all 1 papers on beta-adrenergic receptor blocker

  • Humans1

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 01 paper in 12 months
ESC Congress 2026 Abstract

Four heart failure drugs linked to fewer deaths in older adults

Thirty-day mortality was 2.9% among older patients discharged on all four recommended drug types, versus 19.1% among those prescribed three or fewer.Thirty-day mortality was 2.9% among older patients discharged on all four recommended drug types, versus 19.1% among those prescribed three or fewer.

Cohort · 1,868 peoplePopulations